Aduro Biotech, Inc.
Extract: Charter Amendment (Plain English Desc) from a 8-K on 10/01/2020   Download
SEC Document
SEC Filing

At the Special Meeting of Stockholders of Aduro Biotech, Inc. (the “Company” or “Aduro”) held on October 1, 2020, virtually, (the “Special Meeting”), as described below, the Company’s stockholders approved an amendment to the amended and restated certificate of incorporation of Aduro to effect a reverse stock split of Aduro’s issued and outstanding common stock within a range, as determined by the Aduro board of directors, of every two to five shares (or any number in between) of outstanding Aduro common stock being combined and reclassified into share of Aduro common stock (the “Charter Amendment”).

On October 1, 2020, the Company filed the Charter Amendment with the Secretary of State of the State of Delaware to effect the reverse stock split. As a result of the reverse stock split, the number of issued and outstanding shares of Aduro’s common stock immediately prior to the reverse stock split was reduced to a smaller number of shares, such that every five shares of Aduro’s common stock held by a stockholder immediately prior to the reverse stock split were combined and reclassified into one share of Aduro’s common stock.